People with end stage ALS lose the ability to breathe, have limited mobility as muscles become paralyzed, and may no longer be able to speak. Amyotrophic lateral sclerosis (ALS) affects certain nerve ...
Clinical Trials Arena on MSN
Spinogenix’s ALS hopeful to advance to registrational trial
"Spinogenix’s ALS hopeful to advance to registrational trial" was originally created and published by Clinical Trials Arena, ...
SPG302 was well tolerated in a trial, with preliminary data supporting the idea the therapy might slow ALS progression.
The early-stage pipeline for amyotrophic lateral sclerosis drugs exploded last year. After ALS R&D notched 28 new trial starts in 2023, the rate more than doubled to 60 in 2024, Citeline recently ...
Spinogenix received FDA authorization earlier this year for an Expanded Access Program, providing access to 200 ALS individuals ineligible for clinical trials in the United States. SPG302 has also ...
The 36-year-old content creator posted a "dying diary" to describe the feeling of her progressing paralysis Zoey Lyttle is a Society & Culture Writer-Reporter at PEOPLE. She covers influencers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback